Defending Against an OFAC Investigation

Sponsored by ComplianceOnline
Tuesday, February 28, 2012

Time: 1:00 pm ET (12 noon CT, 11:00 am MT, 10:00 am PT)

Length: 60 minutes


Registration - Session Only: $199.00

CD Recording Only: $399.00

 

TELECONFERENCE DESCRIPTION

The U.S. government takes violations of economic sanctions prohibitions very seriously. Just recently, JP Morgan Chase had to pay $88.3 million to settle allegations that it had violated a number of OFAC administered sanctions prohibitions. This type of penalty is not abnormal as for most sanctions violations OFAC can administered penalties of up to $250,000 USD or twice the value of the transaction, per transaction that violated the sanctions. As there is lack of information publically available many are lost when it comes down to how an OFAC investigation and enforcement action should be handled.

Defending against an investigation from the United States Department of the Treasury Office of Foreign Assets Control (OFAC) can be a stressful process. Careful navigation and understanding of this process is required to shield one’s self or company from massive penalties and reputational risk.

This webinar is designed to teach participants how to successfully navigate the OFAC enforcement process and reduce any OFAC penalties.

AREAS COVERED IN THE SEMINAR
  • The Art of the OFAC Voluntary Self-Disclosure: What to do when you have violated U.S. economic sanctions; but OFAC is unaware.
  • Responding to OFAC Administrative Subpoenas.
  • What OFAC enforcement officers are really looking for?
  • Using the OFAC enforcement guidelines to your advantage.
  • Types of enforcement actions and penalty calculations.
  • Responding to a pre-penalty notice and saving your reputation in light of the sanctions violations.
WHO WILL BENEFIT
  • Banks and financial institutions
  • Insurers
  • Importers/exporters
  • Any entity or person engaged in international trade particularly in the Middle East
  • General Counsels of U.S. and Multi-National Corporations
  • Agricultural and food suppliers
  • Pharmaceutical companies
  • Manufacturers and distributors of medical devices and products
INSTRUCTOR PROFILE

Mr. Ferrari, represents both private individuals and entities in a variety of matters before OFAC seeking to not only protect their rights in current legal matters, but also to make certain that they become informed and aware of what it takes to comply with U.S. trade sanctions. Due to the reach of U.S. trade sanctions law, a number of Mr. Ferrari’s clients are located in various parts of the U.S. and in several countries across the world.

Mr. Ferrari’s representations before OFAC frequently involve investigations concerning violations of the Iranian Transactions Regulations, the Cuban Assets Control Regulations, and the Narcotics Trafficking Sanctions Regulations. As part of these representations, Mr. Ferrari has worked to have individuals names removed from OFAC’s Specially Designated Nationals list, answer administrative subpoenas issued during the course of an OFAC investigation, procure OFAC specific licenses to engage in transactions prohibited by OFAC, draft voluntary self-disclosures, develop and implement OFAC compliance programs for international import-export companies, and provide general counseling on OFAC related matters.

Mr. Ferrari actively writes on OFAC administered trade sanctions and has been published on the matter. In addition, he is often called upon by media outlets to speak on U.S. trade sanctions issues. He has been interviewed on OFAC related issues by CNN, Time Magazine, Forbes Magazine, The New York Times, and Moneylaundering.com. He is the founder and author of a U.S. trade sanctions blog: www.sanctionlaw.com. He is also the author of the Iranian Transactions Regulations Practice Guide.

REGISTER

 

Registration - Session Only: $199.00

CD Recording Only: $399.00

 

Upcoming Teleconferences

Regulatory Perspectives of Clinical Project Management: Meeting FDA Requirements for Clinical Trials
Feb. 28, 2012
Registration - Session Only: $299.00
CD Recording Only: $499.00
Learn More

Dissolution Instrument Qualification to Meet Requirements and
Minimize Product OOS Dissolution Results
Feb. 28, 2012
Registration - Session Only: $349.00
D Recording Only: $599.00
Learn More

Solutions to the Challenges of Phase I and FIM Studies in Today's World
Feb. 29, 2012
Registration - Session Only: $299.00
CD Recording Only: $499.00
Learn More

DMR & DHR - What is Really Required
Feb. 29, 2012
Registration - Session Only: $299.00
CD Recording Only: $549.00
Learn More


SPREAD THE NEWS

Please forward this invitation to colleagues who may benefit from participating.

This message is sent to you by FDANewswatch